NRIX — Nurix Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Nurix Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

	2020 November 30th	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	281	295	309	288	610
Net Total Accounts Receivable
Net Total Receivables	11.3	6.2	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	298	311	318	296	619
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.67	25.3	29.5	48	45.9
Long Term Investments
Other Long Term Assets
Total Assets	396	477	417	356	669
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	44.5	66.3	70.7	87	95.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	106	134	113	155	142
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	290	342	304	200	527
Total Liabilities & Shareholders' Equity	396	477	417	356	669
Total Common Shares Outstanding